Form 4 for MRNA Moderna
Accepted 2024-05-07 00:00:00 ET · period of report 2024-05-03 · accession 0001127602-24-014476 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-07 | 2024-05-03 | MRNA | Berenson Stephen | Dir | M - OptEx | — | +732 | 22.2K | +3% | — |
| D | 2024-05-07 | 2024-05-06 | MRNA | Berenson Stephen | Dir | A - Grant | $0.00 | +7,557 | 7,557 | New | $0 |
| D | 2024-05-07 | 2024-05-03 | MRNA | Berenson Stephen | Dir | M - OptEx | $0.00 | -732 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-03 | M | A | 732 | — | 22,203 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-05-06 | A | A | 7,557 | $0.00 | 7,557 | D | $122.13 · — to 2034-05-06 | 7,557 Common Stock | (F3) This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. |
| 3 | Derivative | Restricted Stock Units | 2024-05-03 | M | D | 732 | $0.00 | 0 | D | — · — to — | 732 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) The shares subject to this restricted stock unit award vested in full on May 3, 2024. |